Overview
Status
Active
Registry date
2022-10-12
Share capital
50,000.00 PLN
Registered address
Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Katarzyna Agata Koziak – President of the Management Board
Joanna Edyta Hetnarowicz – Management Board Member
Rafał Szymon Mikołajczuk – Management Board Member
Manner of representation
In the case of a one-person management board, the member of the management board is authorised to represent the company independently, including to sign and submit declarations of will on behalf of the company. In the case of a multi-member management board, the representation of the company, including the signing and submission of declarations of will on behalf of the company, requires the joint action of two members of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $6,753.11 | 50% | |
| 50 | $6,753.11 | 50% |
Beneficial owners
No beneficial owners recorded for the company Vewin.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 8, 2026 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com | ||
| LASTsp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-11 | Address change (Ul. Modlińska 175a/7, 03-186, Warszawa → Warszawa) | |
| 2022-10-12 | Entered in the register |
FAQ
The main business activity of Vewin focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 12, 2022.
The headquarters is located at: Warszawa.
The management board includes: Joanna Edyta Hetnarowicz (Member of the Management Board) and Rafał Szymon Mikołajczuk (Member of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
Last updated: 2026-04-17